Evidence map›Paper›PMID 17849429›Full record

ArticleJournal of cellular biochemistry2008

Expression of serum amyloid A transcripts in human bone tissues, differentiated osteoblast-like stem cells and human osteosarcoma cell lines.

Alenka Kovacevic, Astrid Hammer, Elke Stadelmeyer, Werner Windischhofer, Monika Sundl, Alpana Ray, Natascha Schweighofer, Gerald Friedl, Reinhard Windhager, Wolfgang Sattler and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. SAA4: An Underdog Within the Serum Amyloid a Superfamily?International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Serum amyloid A - a review.Molecular medicine (Cambridge, Mass.) · 2018
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. The cytokine-serum amyloid A-chemokine network.Cytokine & growth factor reviews · 2016
    Review
  17. Article
  18. Review
  19. Acute-phase protein serum amyloid A3 is a novel paracrine coupling factor that controls bone homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Alenka KovacevicInstitute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University of Graz, Center of Molecular Medicine, Graz, Austria.
Astrid Hammer
Elke Stadelmeyer
Werner Windischhofer
Monika Sundl
Alpana Ray
Natascha Schweighofer
Gerald Friedl
Reinhard Windhager
Wolfgang Sattler
Ernst Malle
Medical University of Graz · ATGraz University Hospital · ATUniversity of Missouri · US

Funding

Austrian Science Fund FWF P 17013Austrian Science Fund FWF P 19074
6 · The paper itself

Abstract

Although the liver is the primary site of cytokine-mediated expression of acute-phase serum amyloid A (SAA) protein, extrahepatic production has also been reported. Besides its role in amyloidosis and lipid homeostasis during the acute-phase, SAA has recently been assumed to contribute to bone and cartilage destruction. However, expression of SAA in human osteogenic tissue has not been studied. Therefore, we first show that SAA1 (coding for the major SAA isoform) but not SAA2 transcripts are expressed in human trabecular and cortical bone fractions and bone marrow. Next, we show expression of (i) IL-1, IL-6, and TNF receptor transcripts; (ii) the human homolog of SAA-activating factor-1 (SAF-1, a transcription factor involved in cytokine-mediated induction of SAA genes); and (iii) SAA1/2 transcripts in non-differentiated and, to a higher extent, in osteoblast-like differentiated human mesenchymal stem cells. Third, we provide evidence that human osteoblast-like cells of tumor origin (MG-63 and SAOS-2) express SAF-1 under basal conditions. SAA1/2 transcripts are expressed under basal conditions (SAOS-2) and cytokine-mediated conditions (MG-63 and SAOS-2). RT-PCR, Western blot analysis, and immunofluorescence technique confirmed cytokine-mediated expression of SAA on RNA and protein level in osteosarcoma cell lines while SAA4, a protein of unknown function, is constitutively expressed in all osteogenic tissues investigated.

Indexed as

Transcription, GeneticAcute-Phase ReactionAgedBiomarkers, TumorBone and BonesCell DifferentiationCells, CulturedFemaleGene ExpressionHumansInterleukin-1Interleukin-6LiverMaleMolecular Sequence DataOsteoblastsBiomarkers, TumorInterleukin-1Interleukin-6Receptors, Tumor Necrosis FactorRNA, MessengerSerum Amyloid A ProteinTumor Necrosis Factor-alpha

Identifiers

PMID17849429
PMCPMC4861207
OpenAlexW1977300376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.